Stocks · Health care · Services-Medical Laboratories

BIODESIX INC

BDSX Clue Score48
United States Fiscal year ends December CIK 0001439725 Results filed 5 Nov 2026

What the insiders did Net buying

By person

11 insiders · 26 transactions
1.8×

Scott Hutton holds only 1.8 times base salary in stock. $1.19M of shares against $643.40K in salary for 2025.

Salary from the company's own proxy. The shares are what Scott Hutton last reported holding, valued at $24.47, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Jack W Schuler
10% owner
$3.12M (6)
—
+$3.12M
555,810
$13.60M
—
Scott Hutton
President & CEO
—
$64.27K (4)
−$64.27K
48,767
$1.19M
—
Robin Harper Cowie
CFO, Sec'y & Treasurer
—
$19.13K (4)
−$19.13K
16,231
$397.11K
—
Kieran O'Kane
Chief Commercial Officer
—
$15.34K (4)
−$15.34K
9,819
$240.23K
—
Gary Anthony Pestano
Chief Development Officer
—
$15.15K (4)
−$15.15K
10,359
$253.44K
—
Chris Vazquez
Chief Accounting Officer
—
$4.49K (4)
−$4.49K
1,586
$38.80K
—
Lawrence T. Kennedy Jr
Director
—
—
—
10,411,024
$254.72M
+0.5%
Charles M Watts
Director
—
—
—
421,705
$10.32M
+12.4%
John Patience
Director
—
—
—
378,536
$9.26M
+25.1%
Hany Massarany
Director
—
—
—
310,135
$7.59M
+9.3%
Jean M. Franchi
Director
—
—
—
108,140
$2.65M
+32.2%

No percentages here. This company's share count has moved by a factor of 18.4 over the window, from 7,955,685 to 146,633,352 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.